Submit Your Questions for the May 4 Virtual Town Hall for SARS-CoV-2 Test Developers

The FDA will answer questions about the development and validation of tests for SARS-CoV-2

If your email program has trouble displaying this email, view as a webpage. Virtual Town Hall for SARS-CoV-2 Test Developers On Wednesday, May 4, 2022, from 12:05 p.m.-1:00 p.m. ET, the U.S. Food and Drug Administration (FDA) will host the next virtual Town Hall for SARS-CoV-2 test developers. During this Town Hall, the FDA will answer technical questions about the development and validation of tests for SARS-CoV-2. Panelists include: Timothy Stenzel, M.D., Ph.D., Director of the Office of In Vitro Diagnostics Toby Lowe, Associate Director for Regulatory Programs, Office of In Vitro Diagnostics Kristian Roth, Ph.D., Deputy Director of the Division of Microbiology Devices, Office of In Vitro Diagnostics There will be an opportunity to ask questions live on the call, but questions may also be submitted in advance by emailing CDRHWebinars@fda.hhs.gov. Submit questions by Monday, May 2, 2022, by 12 p.m. ET. In the subject line of the email, state "Question for the COVID-19 Test Virtual Town Hall" View the Town Hall Details Previous Virtual Town Halls Recordings, printable slides, and transcripts from previous Town Halls are available on the FDA website. Questions? For general questions, including about this Town Hall, contact Division of Industry and Consumer Education. For specific questions about COVID-19 diagnostic development, contact CDRH-EUA-Templates@fda.hhs.gov.

Follow us on Twitter at @FDADeviceInfo Manage Subscriptions  |  Unsubscribe All  |  Help

This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA